Comparison of ADAMTS13 and Von Willebrand factor antigen levels and activities and plasminogen levels, in the currently available plasma products for the treatment of thrombotic thrombocytopenic purpura in South Africa

Simple item page
dc.contributor.advisorJoubert, Jaco
dc.contributor.authorVan Marle, Anneke
dc.date.accessioned2019-12-05T06:34:38Z
dc.date.available2019-12-05T06:34:38Z
dc.date.issued2018
dc.description.abstractThrombotic thrombocytopenic purpura results from a deficiency in the Von Willebrand factor cleaving protease, ADAMTS13. Treatment involves plasma exchange therapy with either fresh frozen plasma, cryosupernatant, or solvent/detergent-treated plasma (available locally as Bioplasma FDP®). The research aimed to generate in vitro data on these products, and to explore possible differences between them that may offer treatment advantages. Twenty samples per product were analysed for levels and activities of ADAMTS13 and Von Willebrand factor, and plasminogen levels (a proposed physiological backup system for ADAMTS13). Fresh frozen plasma and cryosupernatant samples were subanalysed according to ABO blood group. All samples had normal/high ADAMTS13 activity and plasminogen levels. Von Willebrand factor content was mostly normal for Bioplasma FDP®, typically deficient for cryosupernatant and mostly (unexpectedly) deficient for fresh frozen plasma. Depending on the parameter, Bioplasma FDP® was the most standardised (CV: 14.1% to 27.3%), whilst fresh frozen plasma showed great inter-individual variation (CV: 24.6% to 208.6%). Statistically significant differences were found across products (p values ≤ 0.0095) and ABO blood groups (p value: 0.0001). In conclusion, all three products can be used for treatment of thrombotic thrombocytopenic purpura. Product choice depends on the need for additional viral safety, costs, product availability and the perceived impact of within-product variations.en_ZA
dc.identifier.urihttp://hdl.handle.net/11660/10360
dc.language.isoenen_ZA
dc.publisherUniversity of the Free Stateen_ZA
dc.rights.holderUniversity of the Free Stateen_ZA
dc.subjectThrombotic thrombocytopenic purpuraen_ZA
dc.subjectVon Willebrand factoren_ZA
dc.subjectADAMTS13en_ZA
dc.subjectPlasminogenen_ZA
dc.subjectFresh frozen plasmaen_ZA
dc.subjectCryosupernatanten_ZA
dc.subjectSolvent/detergent-treated plasmaen_ZA
dc.subjectDissertation (M.Sc. (Haematology and Cell Biology))--University of the Free State, 2018
dc.titleComparison of ADAMTS13 and Von Willebrand factor antigen levels and activities and plasminogen levels, in the currently available plasma products for the treatment of thrombotic thrombocytopenic purpura in South Africaen_ZA
dc.typeDissertationen_ZA
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
VanMarleA.pdf
Size:
2.1 MB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.76 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
All Electronic Theses and Dissertations
Masters Degrees (Haematology and Cell Biology)